As of 12:26pm ET
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 2.50. The median estimate represents a +58.73% increase from the last price of 1.89.
The current consensus among 7 polled investment analysts is to Hold stock in MEI Pharma Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.